Filtros de búsqueda

Lista de obras de John W. Eikelboom

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

artículo científico publicado en 2017

A Replacement for Warfarin

A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score

artículo científico publicado en 2016

A Test in Context: D-Dimer

artículo científico publicado en 2017

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

artículo científico publicado en 2017

A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study

artículo científico publicado en 2014

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)

artículo científico publicado en 2012

A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty

artículo científico publicado en 2010

A guide to GRADE guidelines for the readers of JTH.

artículo científico

A national survey of Canadian practice patterns of warfarin after anterior wall myocardial infarction in the current era of dual antiplatelet therapy

artículo científico publicado en 2010

A response to - There's madness in their methods

A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal

artículo científico publicado en 2015

ACP Journal Club. Review: New oral anticoagulants increase GI bleeding in venous thrombosis and ACS.

artículo científico

ACP Journal Club: Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation

artículo científico publicado en 2009

Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial.

artículo científico publicado en 2009

Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial

artículo científico publicado en 2015

Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks

artículo científico publicado en 2005

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

artículo científico publicado en 2014

Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction

artículo científico publicado en 2004

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

artículo científico publicado en 2006

Altered preoperative coagulation and fibrinolysis are associated with myocardial injury after non-cardiac surgery

artículo científico publicado en 2017

American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?

artículo científico publicado en 2009

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

artículo científico publicado en 2016

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

scientific article published on 27 September 2020

Another oral thrombin inhibitor for stroke prevention in atrial fibrillation?

Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis

artículo científico publicado en 2013

Anticoagulant therapy in acute brain ischaemia

artículo científico publicado en 2013

Anticoagulants for patients with prosthetic heart valves – Authors' reply

scientific article published in The Lancet

Anticoagulants in atrial fibrillation patients with chronic kidney disease

artículo científico

Anticoagulants in patients with atrial fibrillation and end-stage renal disease

artículo científico publicado en 2012

Anticoagulation for Mechanical Heart Valves: Will Oral Factor Xa Inhibitors Be Effective?

artículo científico publicado en 2017

Anticoagulation for ST-Segment Elevation Myocardial Infarction

Anticoagulation for venous thromboembolism

artículo científico publicado en 2007

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants

artículo científico publicado en 2013

Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion

scholarly article by Sam Schulman et al published April 2013 in Thrombosis Research

Anticoagulation therapy. Dabigatran and risk of myocardial infarction

artículo científico publicado en 2012

Antiplatelet agents in acute coronary syndromes

artículo científico publicado en 2003

Antiplatelet drugs

artículo científico publicado en 2003

Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Antiplatelet therapy and cardiac surgery: review of recent evidence and clinical implications

artículo científico publicado en 2013

Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial

artículo científico publicado en 2012

Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review

artículo científico publicado en 2008

Antiplatelet therapy in prevention of cardio- and venous thromboembolic events

artículo científico

Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation

Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes

article

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update

artículo científico publicado en 2016

Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses

artículo científico publicado en 2016

Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events

scientific article published on March 2010

Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends

artículo científico publicado en 2009

Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves

artículo científico

Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation

artículo científico

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary

artículo científico publicado en 2011

Antithrombotic treatment for peripheral arterial disease

artículo científico publicado en 2007

Aortic valve replacement in younger patients

artículo científico publicado en 2017

Apixaban in Patients with Atrial Fibrillation ⬇️

artículo científico publicado el 10 de febrero de 2011

Apixaban in acute coronary syndromes

artículo científico publicado en 2010

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial

artículo científico publicado en 2012

Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease

artículo científico publicado en 2019

Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions

artículo científico publicado en 2014

Appropriate Apixaban Dosing: Prescribers Take Note.

artículo científico publicado en 2016

Aspirin

scientific article published in March 2012

Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration

artículo científico publicado en 2014

Aspirin for the primary prevention of cardiovascular events

artículo científico publicado en 2002

Aspirin in patients undergoing noncardiac surgery

artículo científico publicado en 2014

Aspirin resistance

artículo científico publicado en 2004

Aspirin resistance

artículo científico publicado en 2006

Aspirin resistance

artículo científico publicado en 2007

Aspirin resistance and its implications in clinical practice

artículo científico publicado en 2005

Aspirin resistance: a new independent predictor of vascular events?

artículo científico publicado en 2003

Aspirin resistance: does it exist and is it an important clinical problem?

artículo científico publicado en 2006

Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of

article

Aspirin response variability after major orthopedic surgery

article published in 2012

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding

artículo científico publicado en 2009

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

artículo científico publicado en 2002

Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants

artículo científico publicado en 2013

Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery

artículo científico publicado en 2007

Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke

artículo científico publicado en 2000

Association between phosphodiesterase 4D gene and ischaemic stroke

artículo científico publicado en 2006

Association of atrial fibrillation with mortality and disability after ischemic stroke

artículo científico publicado en 2013

Association of cardiac biomarkers with acute kidney injury after cardiac surgery: A multicenter cohort study

artículo científico publicado en 2016

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

artículo científico publicado en 2014

Atrial fibrillation is associated with increased mortality: causation or association?

article published in 2013

B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke: the VITAmins TO Prevent Stroke (VITATOPS) MRI-substudy

artículo científico

Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation

artículo científico publicado en 2013

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

artículo científico publicado en 2008

Betrixaban (PRT054021): pharmacology, dose selection and clinical studies

artículo científico publicado en 2014

Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa).

artículo científico publicado en 2013

Beyond unfractionated heparin and warfarin: current and future advances

artículo científico publicado en 2007

Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance

artículo científico publicado en 2020

Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2007

Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk

scientific article published on October 2007

Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vit

artículo científico

Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study

artículo científico publicado en 2017

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology

artículo científico publicado en 2011

Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study

artículo científico publicado en 2016

Bleeding risk in atrial fibrillation patients taking vitamin K antagonists: systematic review and meta-analysis

artículo científico publicado en 2013

Bleeding with direct oral anticoagulants vs warfarin: clinical experience

artículo científico publicado en 2016

Bone marrow biopsy in thrombocytopenic or anticoagulated patients

scientific article published on 01 May 2005

Broadsheet number 53: Activated protein C resistance: diagnosis and clinical management

artículo científico publicado en 1999

C-reactive protein in ischemic stroke and its etiologic subtypes

artículo científico publicado en 2003

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

scientific article published on 15 April 2020

CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention

Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohort

artículo científico publicado en 2022

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial

Cardiac biomarkers and acute kidney injury after cardiac surgery

artículo científico publicado en 2015

Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial

scientific article published on 08 May 2020

Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions: we need processes in place to follow up suspicions about serious adverse events.

artículo científico publicado en 2004

Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study

artículo científico publicado en 2013

Challenges of establishing new antithrombotic therapies in atrial fibrillation

artículo científico publicado en 2007

Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial

artículo científico publicado en 2015

Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.

artículo científico publicado en 2017

Chills and limb pain following administration of low-molecular-weight heparin for treatment of acute venous thromboembolism

artículo científico publicado en 2011

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

artículo científico publicado en 2016

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

artículo científico publicado en 2016

Ciraparantag for enoxaparin reversal: Adding to the evidence.

artículo científico publicado en 2016

Clinical factors influencing the sensitivity to warfarin when restarted after surgery

artículo científico publicado en 2008

Clinical implications of reversal agents for direct oral anticoagulants

artículo científico publicado en 2017

Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)

artículo científico publicado en 2006

Clinical usefulness of plasma homocysteine in vascular disease

artículo científico publicado en 2004

Clonidine in patients undergoing noncardiac surgery

artículo científico

Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes

artículo científico publicado en 2002

Clopidogrel resistance: more grist for the mill

artículo científico publicado en 2008

Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices

artículo científico publicado en 2014

Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism

artículo científico publicado en 2010

Colchicine for secondary prevention of cardiovascular disease

artículo científico publicado en 2014

Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2015

Collagen platelet receptor polymorphisms integrin alpha2beta1 C807T and GPVI Q317L and risk of ischemic stroke

artículo científico publicado en 2003

Combined antiplatelet and anticoagulant therapy: clinical benefits and risks

artículo científico publicado en 2007

Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes

artículo científico publicado en 2015

Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation

artículo científico publicado en 2018

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial

artículo científico publicado en 2017

Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial

artículo científico publicado en 2009

Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations

artículo científico publicado en 2017

Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation

artículo científico publicado en 2018

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

artículo científico publicado en 2012

Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes

Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective

artículo científico publicado en 2011

Corrigendum to "Dabigatran in clinical practice: Contemporary overview of the evidence" [Int. J. Cardiol. 220 (2016) 417-428].

artículo científico publicado en 2016

Current evidence for genetic testing in clopidogrel-treated patients undergoing coronary stenting

artículo científico

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

artículo científico publicado en 2002

Cyclooxygenase-2 inhibitors: are they really atherothrombotic, and if not, why not?

artículo científico publicado en 2003

D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.

artículo científico publicado en 2016

Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?

artículo científico publicado en 2013

Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation

artículo científico publicado en 2012

Dabigatran etexilate and reduction in serum apolipoprotein B

artículo científico publicado en 2015

Dabigatran etexilate for prevention of venous thromboembolism

artículo científico publicado en 2009

Dabigatran etexilate: a new oral thrombin inhibitor

artículo científico publicado en 2011

Dabigatran for patients with a mechanical valve

Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial

Dabigatran in clinical practice: Contemporary overview of the evidence

artículo científico publicado en 2016

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

artículo científico publicado en 2018

Dabigatran versus warfarin in patients with atrial fibrillation

artículo científico publicado en 2009

Dabigatran versus warfarin in patients with mechanical heart valves

artículo científico publicado en 2013

Dabigatran versus warfarin in patients with mechanical heart valves: reply.

artículo científico publicado en 2014

Deep Vein Thrombosis Prophylaxis: Response

article

Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE).

artículo científico publicado en 2018

Detection of protein s deficiency: a new functional assay compared to an antigenic technique

artículo científico publicado en 2000

Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease

artículo científico publicado en 2019

Direct thrombin inhibitors in acute coronary syndromes

scientific article published in The Lancet

Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention

article

Direct thrombin inhibitors in cardiovascular disease

artículo científico

Direct-acting oral anticoagulants: the brain gets a break

artículo científico publicado en 2013

Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?

artículo científico publicado en 2009

Does this patient have pulmonary embolism?

artículo científico publicado en 2003

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes ⬇️

artículo científico publicado el 2 de septiembre de 2010

Double-dose clopidogrel in patients undergoing PCI for ACS – Authors' reply

artículo científico publicado en 2011

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial ⬇️

artículo científico publicado el 9 de octubre de 2010

Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society

artículo científico publicado en 2009

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

artículo científico publicado en 2020

Duration of red cell storage before transfusion and in-hospital mortality

artículo científico publicado en 2010

ESPRIT trial

artículo científico publicado en 2006

Editorial Comment—Routine Thrombophilia Testing in Stroke Patients Is Unjustified

article

Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease

article

Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis

artículo científico

Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events: A Mendelian Randomization Analysis

artículo científico

Effect of PON1 Q192R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events Trial and the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Va

scholarly article by Guillaume Paré et al published April 2012 in Circulation: Cardiovascular Genetics

Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion

artículo científico publicado en 2016

Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study

artículo científico publicado en 2009

Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study

artículo científico publicado en 2016

Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial

article

Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial

artículo científico publicado en 2009

Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure

artículo científico publicado en 2015

Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events

artículo científico publicado en 2016

Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials

artículo científico publicado en 2011

Effects of CYP2C19 genotype on outcomes of clopidogrel treatment

artículo científico publicado en 2010

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

artículo científico publicado en 2009

Effects of dabigatran according to age in atrial fibrillation

artículo científico publicado en 2017

Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial

artículo científico publicado en 2015

Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials

artículo científico

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

artículo científico publicado en 2010

Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis

artículo científico publicado en 2018

Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis

artículo científico

Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.

artículo científico publicado en 2014

Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial

artículo científico publicado en 2010

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial

artículo científico publicado en 2007

Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials

artículo científico

Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention

artículo científico publicado en 2002

Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation

artículo científico publicado en 2016

Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes

artículo científico publicado en 2003

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial

artículo científico publicado en 2005

Erratum to: New pharmacotherapy for stroke prevention in atrial fibrillation

scholarly article published in Advances in Therapy

Erratum to: Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin

scholarly article published in Journal of Thrombosis and Thrombolysis

Ethnicity does not affect the homocysteine-lowering effect of B-vitamin therapy in Singaporean stroke patients

artículo científico publicado en 2009

Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants

artículo científico

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

scientific article published on 01 September 2020

Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant

artículo científico publicado en 2004

Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants

artículo científico publicado en 2016

Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia.

artículo científico publicado en 1997

Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses

artículo científico publicado en 2014

Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood

artículo científico publicado en 2015

Extended-duration new oral anticoagulants for venous thromboprophylaxis in patients undergoing total hip arthroplasty: a meta-analysis of the randomized controlled trials

artículo científico publicado en 2014

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

artículo científico publicado en 2001

Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2016

External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry

artículo científico publicado en 2017

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

artículo científico publicado en 2015

Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practice

artículo científico publicado en 2004

Folic acid-based multivitamin therapy to prevent stroke: the jury is still out.

artículo científico publicado en 2004

Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.

artículo científico publicado en 2009

Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series

artículo científico publicado en 2011

Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding

artículo científico publicado en 2013

Gastrointestinal bleeding after acute ischemic stroke

artículo científico publicado en 2008

Genetic determinants of dabigatran plasma levels and their relation to bleeding

artículo científico publicado en 2013

Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy

artículo científico publicado en 2016

Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation. A systematic review and meta-analysis

artículo científico publicado en 2015

Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

artículo científico publicado en 2017

Guidelines for anticoagulant use in acute coronary syndromes

artículo científico publicado en 2008

Guidelines for anticoagulant use in acute coronary syndromes – Authors' reply

scientific article published in The Lancet

Guidelines for the management of acute coronary syndromes 2006.

artículo científico publicado en 2007

High prevalence of abnormal preoperative coagulation tests in patients with adolescent idiopathic scoliosis

artículo científico publicado en 2005

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

artículo científico publicado en 1999

Homocysteine and stroke

Homocysteine and stroke

artículo científico publicado en 2005

Homocysteine or renal impairment: which is the real cardiovascular risk factor?

artículo científico publicado en 2008

Homocysteine--should we screen and treat in preventive cardiology programs?

artículo científico publicado en 2006

Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized subs

artículo científico publicado en 2004

How can we reduce disagreement among guidelines for venous thromboembolism prevention?

artículo científico publicado en 2010

Idarucizumab for Dabigatran Reversal

artículo científico publicado en 2015

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis

artículo científico publicado en 2017

Idarucizumab: The Antidote for Reversal of Dabigatran

artículo científico publicado en 2015

Idrabiotaparinux treatment for venous thromboembolism

artículo científico publicado en 2011

Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction

artículo científico publicado en 2001

Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes

artículo científico publicado en 2011

Importance of family history as a risk factor for venous thromboembolism.

artículo científico publicado en 2011

Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes

artículo científico publicado en 2008

Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk

artículo científico publicado en 2008

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A COllaboration between Multiple inst

scientific article published on 06 December 2020

Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention

artículo científico publicado en 2016

Inherited thrombophilia and pregnancy associated venous thromboembolism

artículo científico publicado en 2007

Inherited thrombophilia in ischemic stroke and its pathogenic subtypes

artículo científico publicado en 2001

Insights into myocardial infarction after noncardiac surgery in patients with a prior coronary artery stent.

artículo científico publicado en 2016

Interleukin-6 and interleukin-10 as acute kidney injury biomarkers in pediatric cardiac surgery

artículo científico publicado en 2015

Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure?

artículo científico publicado en 2004

Is there really misuse and abuse of dabigatran?

Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review

artículo científico publicado en 2017

Laboratory measurement of the direct oral anticoagulants

artículo científico publicado en 2015

Latest medical treatment strategies for venous thromboembolism

artículo científico publicado en 2007

Letter by Van de Werf et al Regarding Article, “Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians”

Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial.

artículo científico publicado en 2014

Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation

artículo científico publicado en 2016

Long-term management of venous thromboembolism: is there a role for low-intensity warfarin therapy?

artículo científico publicado en 2003

Low molecular weight heparins and heparinoids.

artículo científico publicado en 2002

Low rates of preventive practices in patients with peripheral vascular disease.

artículo científico publicado en 1999

Low-dose aspirin for preventing recurrent venous thromboembolism

artículo científico publicado en 2012

Low-dose colchicine for secondary prevention of cardiovascular disease

artículo científico publicado en 2012

Low-molecular-weight heparin as an adjunct to thrombolysis in ST elevation myocardial infarction.

artículo científico publicado en 2009

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials

artículo científico publicado en 2004

Low-molecular-weight heparin for the treatment of venous thrombosis in patients with adenocarcinoma

artículo científico publicado en 1998

Major Adverse Limb Events in Lower Extremity Peripheral Artery Disease: COMPASS Trial.

artículo científico publicado en 2018

Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials

artículo científico publicado en 2009

Management and outcomes of major bleeding during treatment with dabigatran or warfarin

artículo científico

Management of antiphospholipid antibody syndrome: a systematic review

artículo científico publicado en 2006

Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors?

artículo científico publicado en 2002

Management of peripheral arterial disease in the elderly: focus on cilostazol

artículo científico publicado en 2008

Management of unstable coronary-artery disease

artículo científico publicado en 2000

Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.

artículo científico publicado en 2009

Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma

artículo científico publicado en 2004

Medical treatment of peripheral arterial disease

artículo científico publicado en 2006

Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease

artículo científico publicado en 2015

Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency

artículo científico publicado en 2006

Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients

artículo científico publicado en 2006

Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study

artículo científico publicado en 2013

Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES study

artículo científico publicado en 2014

Monitoring unfractionated heparin with the aPTT: Time for a fresh look

article published in 2006

More on Acutely Injured Patients Receiving Dabigatran

artículo científico publicado en 2012

Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction

artículo científico publicado en 2010

Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial.

artículo científico publicado en 2015

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes

artículo científico publicado en 2014

Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial

artículo científico publicado en 2012

Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis

artículo científico publicado en 2015

New Anticoagulants

artículo científico publicado en 2010

New Anticoagulants for Atrial Fibrillation

New anticoagulants for atrial fibrillation

artículo científico publicado en 2009

New anticoagulants for atrial fibrillation: the beginning of a a new era in stroke prevention.

artículo científico

New antithrombotic agents--insights from clinical trials

artículo científico publicado en 2010

New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

New oral anticoagulants in elderly patients

artículo científico publicado en 2013

New pharmacotherapy for stroke prevention in atrial fibrillation: update 2010.

artículo científico publicado en 2009

Nonbleeding complications of unfractionated and low-molecular weight heparins

artículo científico publicado en 2007

Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant

artículo científico publicado en 2003

Novel oral anticoagulants for atrial fibrillation

artículo científico

Novel oral anticoagulants: a focused review for stroke physicians

artículo científico publicado en 2013

Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism

artículo científico publicado en 2011

Old blood bad? Either the biggest issue in transfusion medicine or a nonevent

article published in 2012

Once versus twice daily aspirin after coronary bypass surgery: a randomized trial

artículo científico publicado en 2017

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease

artículo científico publicado en 2007

Otamixaban in acute coronary syndromes

artículo científico publicado en 2009

Overexpression of the Multidrug Resistance Protein-4 Transporter in Patients Undergoing Coronary Artery Bypass Graft Surgery

artículo científico publicado en 2011

Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral Anticoagulation

article

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation

artículo científico

Perioperative Aspirin for Prevention of Venous Thromboembolism: The PeriOperative ISchemia Evaluation-2 Trial and a Pooled Analysis of the Randomized Trials

artículo científico

Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.

artículo científico publicado en 2014

Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery

artículo científico publicado en 2015

Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications.

artículo científico publicado en 2004

Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran

article

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial

artículo científico

Pexelizumab Does Not “Complement” Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction

artículo científico publicado en 2007

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

artículo científico publicado en 2020

Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery

artículo científico publicado en 2015

Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future

artículo científico publicado en 2008

Platelet function testing: quality assurance.

artículo científico publicado en 2007

Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke

artículo científico publicado en 2001

Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular disease

scientific article published on May 2010

Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators

artículo científico publicado en 2009

Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study

artículo científico publicado en 2020

Preventing cardioembolic stroke in atrial fibrillation with dabigatran

artículo científico

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention

artículo científico publicado en 2009

Prevention of Thromboembolic Events After Bioprosthetic Aortic Valve Replacement

scientific article published on 22 August 2012

Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness

artículo científico publicado en 2004

Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy

artículo científico publicado en 2014

Processed residual pump blood in cardiac surgery: the Processed Residual Blood in Cardiac surgery trial

artículo científico publicado en 2012

Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism

artículo científico publicado en 2015

Prognostic importance of preoperative anti-PF4/heparin antibodies in patients undergoing cardiac surgery. A systematic review

artículo científico publicado en 2011

Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2)study

artículo científico publicado en 2001

Protein Z Gene Polymorphisms, Protein Z Concentrations, and Ischemic Stroke

article

Protein Z in ischemic stroke and its etiologic subtypes

artículo científico publicado en 2003

Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: a nested case control analysis of the ACTIVE W study

artículo científico publicado en 2011

RE: Bain B.J. (2004) Bone marrow biopsy morbidity and mortality: 2002 data. Clinical and Laboratory Haematology26, 315-318.

artículo científico publicado en 2005

Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy

artículo científico publicado en 2012

Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high-risk neurosurgical patients.

artículo científico publicado en 2012

Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation

artículo científico publicado en 2012

Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Tr

artículo científico publicado en 2009

Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study

artículo científico publicado en 2010

Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study

Rapid reversal of haematoma expansion associated with vitamin K antagonists.

artículo científico publicado en 2016

Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial

artículo científico publicado en 2015

Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

artículo científico publicado en 2010

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

artículo científico publicado en 2017

Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial

artículo científico publicado en 2018

Real-world variability in dabigatran levels in patients with atrial fibrillation

artículo científico publicado en 2015

Recent advances in antidotes for direct oral anticoagulants: their arrival is imminent

artículo científico publicado en 2014

Recombinant activated factor VII for the treatment of life-threatening haemorrhage

artículo científico publicado en 2003

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding

Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemia

artículo científico publicado en 2002

Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study

artículo científico publicado en 2016

Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial

artículo científico publicado en 2017

Red cell N5-methyltetrahydrofolate concentrations and C677T methylenetetrahydrofolate reductase genotype in patients with stroke

artículo científico publicado en 2004

Reducing the risk of recurrent stroke in patients with AF

artículo científico publicado en 2012

Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin

artículo científico publicado en 2012

Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes

artículo científico publicado en 2009

Reply to Letters Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Tria

Reply: Anticoagulant-Related Nephropathy

scientific article published on 01 December 2015

Reply: regarding the effect of dabigatran plasma concentrations

artículo científico publicado en 2014

Response by Weitz and Eikelboom to Letter Regarding Article, "Urgent Need to Measure Effects of Direct Oral Anticoagulants".

artículo científico publicado en 2016

Response to Letter Regarding Article, “Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation”

Response to Letter Regarding Article, “Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk”

Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study"

artículo científico publicado en 2014

Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial a

artículo científico publicado en 2014

Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin"

artículo científico publicado en 2014

Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.

artículo científico publicado en 2013

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study

artículo científico publicado en 2010

Reversal of the anti-platelet effects of aspirin and clopidogrel

article

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

artículo científico publicado en 2018

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

artículo científico

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES.

artículo científico publicado en 2014

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review

artículo científico publicado en 2006

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial

artículo científico publicado en 2011

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

artículo científico publicado en 2021

Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial

artículo científico publicado en 2012

Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery disease

scientific article published on 07 July 2020

Rivaroxaban versus enoxaparin after total knee arthroplasty.

artículo científico publicado en 2009

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

artículo científico publicado en 2017

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2017

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2017

Role of phenotypic and genetic testing in managing clopidogrel therapy

artículo científico publicado en 2014

Role of protein Z in stroke

artículo científico publicado en 2007

Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.

artículo científico publicado en 2010

Routine home treatment of deep vein thrombosis

artículo científico publicado en 2001

Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: Intracranial hemorrhage in trials of bolus thrombolytic therapy

artículo científico publicado en 2001

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation

scientific article published on 09 December 2020

Selective factor Xa inhibition for thromboprophylaxis

artículo científico publicado en 2008

Sex, Stroke, and Atrial Fibrillation

article

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis

artículo científico publicado en 2014

Should Warfarin Be Restarted After Warfarin-Associated Intracranial Hemorrhage?

article published in 2012

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

artículo científico publicado en 2011

Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group

artículo científico publicado en 2009

Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial

artículo científico publicado en 2015

Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

article

Stroke prevention in atrial fibrillation patients with chronic kidney disease

artículo científico

Stroke prevention in atrial fibrillation: Commentary regarding the AAN's evidence-based guideline update

artículo científico publicado en 2014

Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation.

artículo científico

Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease

scientific article published on 02 January 2021

Suboptimal preventive practices in patients with carotid and peripheral vascular occlusive disease in a tertiary referral setting

artículo científico publicado en 2003

Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial

artículo científico publicado en 2012

Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population

artículo científico publicado en 2004

Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants

artículo científico publicado en 2014

Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease

artículo científico

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

artículo científico publicado en 2012

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

artículo científico publicado en 2010

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

artículo científico publicado en 2013

The Outpatient Bleeding Risk Index predicted major bleeding in patients taking warfarin

scientific article published on 01 August 2006

The aspirin controversy in primary prevention

artículo científico publicado en 2012

The association between blood donor sex and age and transfusion recipient mortality: an exploratory analysis

artículo científico publicado en 2018

The beginning of the end of warfarin?

artículo científico publicado en 2004

The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial

artículo científico publicado en 2012

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

artículo científico publicado en 2013

The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial

artículo científico publicado en 2013

The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis

artículo científico publicado en 2008

The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies

artículo científico publicado en 2008

The evolving role of direct thrombin inhibitors in acute coronary syndromes

artículo científico publicado en 2003

The hazards of interrupting anticoagulation therapy in atrial fibrillation

The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia.

artículo científico publicado en 2008

The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?

artículo científico publicado en 2012

The mTORC pathway in the antiphospholipid syndrome.

artículo científico publicado en 2014

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

artículo científico publicado en 2016

The pursuit of clinically relevant measures of platelet function after antiplatelet drug therapy

artículo científico publicado en 2008

The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study

article

The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality

artículo científico publicado en 2008

The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop

artículo científico publicado en 2012

The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia

article by Jane C. Moore et al published 2012 in Thrombosis and Haemostasis

The tip of the iceberg?

artículo científico publicado en 2002

The tissue factor pathway in ischemic stroke

artículo científico publicado en 2006

The use of platelet function assays may help to determine appropriate antiplatelet treatment options in a patient with recurrent stroke on baby aspirin: against

artículo científico publicado en 2010

The value of novel oral anticoagulants in rural Australia

artículo científico publicado en 2018

Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism

article

Thromboprophylaxis practice patterns in hip fracture surgery patients: experience in Perth, Western Australia

artículo científico publicado en 2003

Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.

artículo científico publicado en 2004

Timing the First Postoperative Dose of Anticoagulants: Lessons Learned From Clinical Trials

artículo científico

Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis

artículo científico publicado en 2015

Translational success stories: development of direct thrombin inhibitors

artículo científico publicado en 2012

Treatment With B Vitamins and Incidence of Cancer in Patients With Previous Stroke or Transient Ischemic Attack

article

Treatment of Antiphospholipid Antibody Syndrome—Reply

artículo científico publicado en 2006

Treatment of intermittent claudication

scientific article published in the British Medical Journal

Trends in incidence and prevalence of hospitalisation for atrial fibrillation and associated mortality in Western Australia, 1995–2010

article

Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995-2010.

artículo científico

Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents

artículo científico publicado en 2010

Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients

artículo científico publicado en 2009

Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials

artículo científico publicado en 2005

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis

artículo científico publicado en 2000

Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban

artículo científico publicado en 2015

Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease

artículo científico publicado en 2016

Urgent Need to Measure Effects of Direct Oral Anticoagulants.

artículo científico publicado en 2016

Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial

artículo científico publicado en 2016

Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes

article

Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials

artículo científico publicado en 2008

Using aspirin to prevent cognitive decline

artículo científico publicado en 2008

VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444).

artículo científico publicado en 2007

Validity of composite outcomes in meta-analyses of stroke prevention trials: the case of aspirin

artículo científico publicado en 2011

Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulati

artículo científico

Venous thromboembolism in travellers: can we identify those at risk?

artículo científico

Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting

article by J. Berger et al published April 2013 in Journal of Thrombosis and Haemostasis

Venous thromboembolism: diagnosis and management of deep venous thrombosis

artículo científico publicado en 2005

Venous thromboembolism: diagnosis and management of pulmonary embolism

artículo científico publicado en 2005

Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial

artículo científico publicado en 2010

Warfarin in Heart Failure

Warfarin was not more effective than aspirin and increased adverse events in symptomatic intracranial arterial stenosis

artículo científico publicado en 2005

What do the results of the PRoFESS trial teach us?

article

Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?

artículo científico publicado en 2012

Who Is (Still) Getting HIT?

article

Will prasugrel supersede clopidogrel for acute coronary syndromes?

artículo científico publicado en 2008

Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation?

artículo científico publicado en 2004

von Willebrand Disease Associated with Superficial Temporal Artery Pseudoaneurysm

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda